People · Operator
Named in public records as an officer, director or promoter · active 2007–2007 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Anterion Therapeutics, Inc. | — | Pharmaceuticals | Pre-Seed | $900K | $42.6M | 2007 |
Barry John Unger at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Barry John Unger on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert J. Leonard | 1 | 1 |
| Charles P. Wilkinson | 1 | 1 |
| Kim John Emerling | 1 | 1 |
| Jean-Marie John Vallet | 1 | 1 |
| Richard John Millian | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.